WallStSmart
MGTX

MeiraGTx Holdings PLC

NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY

$9.22
+3.02% today

Updated 2026-04-30

Market cap
$840.42M
P/E ratio
P/S ratio
10.33x
EPS (TTM)
$-1.42
Dividend yield
52W range
$5 – $12
Volume
0.7M

MeiraGTx Holdings PLC (MGTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$13.29M$15.56M$37.70M$15.92M$14.02M$33.28M$81.39M
Revenue growth (YoY)+17.1%+142.2%-57.8%-12.0%+137.4%+144.6%
Cost of revenue$243081.00$679177.00$2.05M$7.87M$8.72M$13.73M$23.79M$4.84M
Gross profit$-243081.00$-679177.00$-2.05M$13.29M$15.56M$37.70M$15.92M$14.02M$9.49M$76.55M
Gross margin100.0%100.0%100.0%100.0%100.0%28.5%94.0%
R&D$14.04M$22.36M$33.62M$24.88M$33.91M$66.69M$85.72M$103.78M$119.48M$129.62M
SG&A$6.03M$9.33M$44.48M$46.68M$44.21M$43.77M$46.55M$47.29M$54.22M$52.90M
Operating income$-20.06M$-31.68M$-78.10M$-58.27M$-62.55M$-72.76M$-116.36M$-137.06M$-164.21M$-105.97M
Operating margin-438.4%-401.9%-193.0%-730.9%-977.8%-493.4%-130.2%
EBITDA$-19.82M$-31.01M$-78.10M$-52.46M$-53.68M$-71.40M$-116.07M$-57.05M$-121.69M$-105.97M
EBITDA margin-394.7%-344.9%-189.4%-729.1%-407.0%-365.7%-130.2%
EBIT$-20.06M$-31.68M$-80.16M$-54.70M$-57.85M$-79.27M$-124.67M$-70.78M$-134.52M
Interest expense$25440.00$42863.00$33429.00$48612.00$139203.00$288000.00$4.95M$13.24M$13.27M$12.20M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-19.49M$-31.04M$-82.87M$-54.75M$-57.99M$-79.56M$-129.62M$-84.03M$-147.79M$-114.20M
Net income growth (YoY)-59.3%-166.9%+33.9%-5.9%-37.2%-62.9%+35.2%-75.9%+22.7%
Profit margin-411.9%-372.6%-211.0%-814.2%-599.5%-444.1%-140.3%